NL-OMON44554已完成不适用
AN OPEN-LABEL, RANDOMIZED, SINGLE DOSE, TWO-TREATMENT (FED VS FASTING), TWO-PERIOD, TWO-SEQUENCE CROSSOVER STUDY TO ASSESS THE EFFECT OF FOOD ON SODIUM OXYBATE FOR EXTENDED RELEASE ORAL SUPENSION (FT218) FORMULATION ADMINISTRERED AT 6 G IN HEALTHY VOLUNTEERS - FT218 PK, FE Study in Healthy Subjects
Flamel Ireland Limited (Ltd) trading under the business name Avadel Ireland0 个研究点目标入组 16 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •healthy male or female
- •age 18 - 55 years, inclusive
- •BMI 18.0 - 28.0 kilograms/meter2, inclusive
- •weight 60.0 kg or more.
- •non smoking
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.
研究者
相似试验
已完成
不适用
A SINGLE-DOSE, TWO-TREATMENT, TWO-PERIOD STUDY OF TWO DIFFERENT FORMULATONS OF CURCUMIN 10 MG ORALLY SOLUBLE TABLET AND CURCUNEX G 5 Mg IN HEALTHY, ADULT, HUMAN, MALE SUBJECTS UNDER FASTING CONDITIONS.CTRI/2021/03/031895KMS Health Center Pvt Ltd3
尚未招募
不适用
A CROSSOVER, ORAL BIOAVAILABILITY STUDY OF INVESTIGATIONAL PRODUCT (ZEAL VITAMIN C) OF PLANT LIPIDS, AND REFERENCE PRODUCT (VITAMIN C) OF PLANT LIPIDS IN HEALTHY, ADULT, HUMAN SUBJECTS UNDER FASTING CONDITIONS.CTRI/2019/07/020159Aurea Biolabs P Ltd
已完成
不适用
A RANDOMIZED, TWO-PERIOD, OPEN-LABEL, SINGLE DOSE CROSSOVER STUDY TO EVALUATE THE BIOEQUIVALENCE OF AQX-1125 IMMEDIATE RELEASE TABLETS AND CAPSULES IN HEALTHY VOLUNTEERSInterstitial Cystitis/Bladder Pain Syndrome (IC/BPS)10004994NL-OMON42576Aquinox Pharmaceuticals (Canada) Inc.18
进行中（未招募）
1 期
AN OPEN-LABEL, RANDOMIZED, SINGLE DOSE, TWO-STAGE CROSSOVER ADAPTIVE BIOEQUIVALENCE STUDY OF TRIAMCINOLONE ACETONIDE 40 MG/ML STERILE INJECTABLE SUSPENSION (Test product–Lisapharma S.p.A) VERSUS KENACORT® 40 MG/ML SUSPENSION (Reference product – Bristol Myers Squibb) AFTER INTRAMUSCULAR ADMINISTRATION TO HEALTHY VOLUNTEERSIntramuscular administration of triamcinolone acetonide Lisapharma (Injectable suspension of triamcinolone acetonide) is indicated for systemic corticosteroid therapy in morbid conditions such as allergic syndrome (to control severe or debilitating conditions not treatable in a conventional way), dermatoses, generalized rheumatoid arthritis and other connective tissue diseases.CTIS2023-509399-40-00aboratorio Italiano Biochimico Farmaceutico Lisapharma S.p.A.30
已完成
不适用
pharmacokinetic study of Livalo complex product in healthy male subjectsKCT0000161JW Pharmaceutical50